Kaye Doiron at SCOPE 2024: Pioneering Innovation in Clinical Research

In February 2024, the clinical research realm witnessed a lively fusion of ideas and camaraderie at the SCOPE Summit in sunny Orlando, Florida. Among the luminaries gracing the stage was Kaye Doiron, the brain behind Research Works, who shared her wisdom on tackling the hurdles of fundraising, scaling, and navigating the ever-shifting landscape of clinical research.

A Gathering of Great Minds

The SCOPE Summit, now in its 15th year, gathered over 4,000 professionals from 850 organizations worldwide. This annual rendezvous has become a hotbed for innovation, showcasing the latest and greatest in clinical trials, operations, and research. Kaye’s presence at this prestigious event underscores Research Works’ commitment to leading the charge in innovation and leaving footprints all over the globe in clinical trial management.

Insights from the Trenches

During her panel discussion, artfully moderated by Blake Wu of NEA, Kaye dove into the intricacies of leadership in today’s fast-paced arena. She pondered the shifts in fundraising strategies, pointing out the trend towards unconventional avenues like debt financing and SBIR grants to fuel growth and innovation in the face of a globally challenging backdrop. Her insights shed light on the delicate dance between securing funding and staying true to the company’s mission.

Plotting the Course Ahead

Kaye’s journey, from founding Women Under Study in 2009 to steering Research Works’ expansion into GI and Hepatology studies, embodies an unyielding quest for excellence in clinical research. Her vision for the company extends beyond conducting studies; it’s about leaving a legacy of top-notch care, ethical research practices, and meaningful contributions to medical science.

The knowledge and connections forged at SCOPE 2024 are poised to propel Research Works into uncharted territories of research innovation and global collaboration. As Kaye Doiron spearheads the charge, the company remains steadfast in its mission to revolutionize patient care through state-of-the-art clinical trials.

A Guiding Light for Future Ventures

Kaye’s participation underscores our commitment to being at the innovation helm to the latest in clinical trial management, operations, and investments. Insights gained not only enhance our capabilities but also reinforces relationships with major partners as Research Works expands globally.

The knowledge and connections fostered at SCOPE will be instrumental in propelling Research Works into new realms of possibility and impact. Our dedication to ongoing collaboration and education creates and sustains the ecosystem where each breakthrough directly enriches the lives of those we serve in our clinics.

By Published On: December 16, 2023Categories: Uncategorized